Hypnion, Inc.

About Hypnion, Inc.

Hypnion, Inc. is a recently founded, privately-held, biotechnology discovery company whose objective is to become the worldwide leader in sleep/wake neurobiology with the ultimate goal of understanding and being able to treat a wide range of sleep-wake disorders (e.g., insomnia, sleep apnea, excessive sleepiness, sleep-related dystonias) and circadian rhythm abnormalities (e.g., jet-lag, shift-work disorders, delayed or advanced sleep phase syndrome). The technology platform assembled for this includes the creation and molecular analysis of mouse models, genetic and genomic based target discovery, a high-throughput in vivo sleep-wake & physiological assay system, and the ability to quickly and efficiently screen pre-clinical compounds for sleep-wake effects or side effects. Additionally, this platform can be applied in many additional areas of CNS for corporate alliances.
Key Management:

Dale M. Edgar, Ph.D. Founder

Karen Moore, Ph.D. Founder

James F. White, Ph.D. Chief Operating Officer and Executive Vice President of Research & Development

John F. Dee President and Chief Executive Officer
Last Updated: 11-01-04